Author:
Matthews John T.,Glass Lucas
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference47 articles.
1. Haffner ME. Orphan drug product regulation—United States. Int J Clin Pharmacol Ther. 2002;40(2):84–88.
2. Cutler DM. The demise of the blockbuster? N Engl J Med. 2007;356(13):1292–1293.
3. Pharmaceutical Research and Manufacturers of America. More than 400 medicines in development to treat or prevent rare diseases. In 2011 Orphan Drugs in Development for Rare Diseases. Washington, DC: Pharmaceutical Research and Manufacturers of America; 1–45.
4. Miller T, Holmes K. 2010 Index of Economic Freedom. Washington, DC: The Heritage Foundation; 2010.
5. Sala-i-Martin X. The Global Competitiveness Report 2010–2011. K Schwab, ed. Geneva: World Economic Forum; 2010.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献